About the Pharmacoepidemiology and Therapeutic Risk Management Session
Pharmacoepidemiology and Therapeutic Risk Management play crucial roles in ensuring the safety and effectiveness of pharmaceutical interventions. This interdisciplinary field examines the real-world impact of medications on large populations, identifying patterns of drug use, adverse effects, and therapeutic outcomes. By analyzing data from diverse sources, including healthcare databases and observational studies, pharmacoepidemiologists evaluate drug safety profiles and assess potential risks. Therapeutic Risk Management focuses on minimizing and managing the risks associated with pharmaceutical products throughout their lifecycle. It involves proactive strategies such as risk assessment, risk communication, and risk mitigation plans. Collaborations between healthcare professionals, regulatory agencies, and pharmaceutical companies are essential for successful risk management. The integration of pharmacoepidemiology and therapeutic risk management enhances patient safety by providing evidence-based insights into the benefits and risks of medications. This information guides healthcare practitioners in making informed decisions, optimizing treatment plans, and improving patient outcomes. Continuous monitoring and evaluation of drug safety contribute to a dynamic and responsive healthcare system, fostering trust in the pharmaceutical industry and regulatory processes.
Topics Covered in Pharmacoepidemiology and Therapeutic Risk Management
Post-marketing drug safety surveillance
Adverse drug reaction monitoring and reporting
Real-world evidence and healthcare databases
Benefit-risk assessment of medicines
Risk minimisation and mitigation planning
Medication use patterns and prescribing safety
Featured Speakers — Pharmacoepidemiology and Therapeutic Risk Management 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Pharmacoepidemiology and Therapeutic Risk Management Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at IPHC 2027
Why Attend the Pharmacoepidemiology and Therapeutic Risk Management Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Pharmacoepidemiology and Therapeutic Risk Management work, reviewed by the scientific committee.
Network Globally
Meet public health researchers, educators, and policy leaders from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Pharmacoepidemiology and Therapeutic Risk Management research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IPHC 2027 for the Pharmacoepidemiology and Therapeutic Risk Management track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Pharmacoepidemiology and Therapeutic Risk Management Conference 2027 — FAQs
What is the Pharmacoepidemiology and Therapeutic Risk Management track at IPHC 2027?
The Pharmacoepidemiology and Therapeutic Risk Management track is a dedicated stream within IPHC 2027 covering the latest research, innovation, and best practice in Pharmacoepidemiology and Therapeutic Risk Management. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Pharmacoepidemiology and Therapeutic Risk Management sessions?
Public health researchers, practitioners, epidemiologists, educators, doctoral students, and policy leaders with an interest in Pharmacoepidemiology and Therapeutic Risk Management are all welcome — whether presenting or attending.
Can I present my research in the Pharmacoepidemiology and Therapeutic Risk Management track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Pharmacoepidemiology and Therapeutic Risk Management sessions?
Yes. IPHC 2027 is a hybrid conference — attend the Pharmacoepidemiology and Therapeutic Risk Management track in person in Singapore or join live online, with on-demand access afterward.
Join the IPHC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.